SCHEMBL137074

SCHEMBL137074

NCC(N)Cc1ccccc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.76
ANPEP P15144 2/20 0.64
SLC6A2 P23975 2/20 0.56
TAAR1 Q96RJ0 2/20 0.56
MAOA P21397 1/20 0.56
SLC6A4 P31645 1/20 0.56
SLC6A3 Q01959 1/20 0.56
SIGMAR1 Q99720 1/20 0.56
CYP2A6 P11509 1/20 0.56
ADORA2A P29274 1/20 0.56
ADORA1 P30542 1/20 0.56
CYP2D6 P10635 1/20 0.52
MMP2 P08253 2/20 0.52
ALPI P09923 1/20 0.50
PKM P14618 1/20 0.50
PTGS1 P23219 1/20 0.50
XIAP P98170 1/20 0.50
SLC7A5 Q01650 1/20 0.50
LOXL2 Q9Y4K0 1/20 0.48
SCN4A P35499 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL243771 1.00 EPHX1 (0.76) EPHX1ANPEPSLC6A2TAAR1MAOA
SCHEMBL3441656 1.00 EPHX1 (0.76) EPHX1ANPEPSLC6A2TAAR1MAOA
SCHEMBL9583547 0.98 EPHX1 (0.73) EPHX1ANPEPSLC6A2TAAR1MAOA
Hydrochloric Acid SCHEMBL18547947 0.98 EPHX1 (0.73) EPHX1ANPEPSLC6A2TAAR1MAOA
Hydrochloric Acid SCHEMBL5567986 0.98 EPHX1 (0.73) EPHX1ANPEPSLC6A2TAAR1MAOA
Ethylene SCHEMBL28827158 0.95 EPHX1 (0.70) EPHX1ANPEPSLC6A2TAAR1MAOA
Acetic Acid SCHEMBL8540401 0.88 ALPI (0.60) EPHX1ANPEPSLC6A2TAAR1MAOA
SCHEMBL28656 0.87 EPHX1 (1.00) EPHX1ANPEPSLC6A2TAAR1MAOA
Hydrochloric Acid SCHEMBL9402300 0.84 EPHX1 (0.94) EPHX1ANPEPSLC6A2TAAR1MAOA
Phenylalanine Amide SCHEMBL10902576 0.83 ALPI (0.59) EPHX1ANPEPMMP2ALPIPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 699 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024079657-A1 FORMULATIONS FOR AAV GENE THERAPY MEIRAGTX UK II LIMITED (GB) 2024-04-18 WO claimed
US-20240092964-A1 IMPREGNATION RESIN FOR A WOVEN OR STITCHED FABRIC SIKA TECHNOLOGY AG (CH) 2024-03-21 US claimed
US-20220194969-A1 METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2022-06-23 US claimed
WO-2020187548-A1 GAS-ACTIVATED CYANOACRYLATES FOR 3D-PRINTING HENKEL AG & CO. KGAA (DE) 2020-09-24 WO claimed
WO-2020130592-A1 METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME 서울대학교산학협력단 2020-06-25 WO claimed
US-10604691-B2 Reversible aminal gel compositions, methods, and use SAUDI ARABIAN OIL COMPANY (SA) 2020-03-31 US claimed
CN-107001590-B Curing agent for epoxy resin and epoxy resin composition using same DIC株式会社 2019-12-06 CN claimed
US-10435583-B2 Curing agent for epoxy resins, and epoxy resin composition obtained using same DIC CORPORATION (JP) 2019-10-08 US claimed
CN-109906078-A (R) preparation of -2- amino -3- Phenylpropylamino formic acid esters 爵士制药国际III有限公司 2019-06-18 CN claimed
CN-109705028-A Pentadentate nitrogen ligand and complex thereof, preparation method and application 西南科技大学 2019-05-03 CN claimed
WO-2006113140-A2 NOVEL COMPOUNDS USEFUL FOR BRADYKININ B1 RECEPTOR ANTAGONISM ELAN PHARMACEUTICALS, INC. (US) 2006-10-26 WO claimed
CN-1649586-A Heterocyclic amide derivatives for the treatment of diabetes and other diseases INCYTE SAN DIEGO INC (US) 2005-08-03 CN claimed
EP-1017358-B1 REDUCTION OF HAIR GROWTH GILLETTE CO (US) 2004-08-11 EP claimed
WO-2001052899-A1 CHELATING AGENTS AND METHOD FOR THEIR USE AS TANDEM METAL CHELATORS AND HYDROPHILIC SPACERS FOR MEDICAL DIAGNOSIS AND THERAPY MALLINCKRODT INC. (US) 2001-07-26 WO claimed
CN-1058496-C Process for isolating or purifying cefonicid and process for preparing salts thereof SMITHKLINE BEECHAM CORP (US) 2000-11-15 CN claimed
US-5939458-A APPLYING AN INHIBITOR OF AMINOACYL-TRNA SYNTHETASE TO THE SKIN GILLETTE COMPANY, THE 1999-08-17 US claimed
CN-1167765-A Process for isolating or purifying cefonicid and process for preparing salts thereof SMITHKLINE BEECHAM CORP (US) 1997-12-17 CN claimed
CN-1036459-C Crystalline benzathine salt of cefonicid and process for its preparation SMITHKLINE BEECHAM CORP. (US) 1997-11-19 CN claimed
CN-1123549-A Crystalline benzathine salt of cefonicid and process for its preparation SMITHKLINE BEECHAM CORP (US) 1996-05-29 CN claimed
US-5378803-A Analgesics, substance P antagonists, peptides containing thiazole, oxazole or imidazole ring and indole ring STERLING WINTHROP INC. (US) 1995-01-03 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220194969-A1 METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME HCN4, SLC46A1, FES EPHX1 3025/4885ANPEP 3505/4885SLC6A2 324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.